Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

201 Results Found

Public

340B Drug Pricing Program

For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription drug costs.
Member

AHA 340B Advocacy Alliance -

The Department of Health and Human Services today issued a request for information on a new 340B rebate model program.
Member

HHS Releases RFI on New 340B Rebate Model

The Department of Health and Human Services today issued a request for information on a new 340B rebate model program. 
Member

AHA 340B Advocacy Alliance Bulletin - February 10, 2026

The AHA has submitted a statement for the hearing and issued a Member Advisory containing several resources to assist hospitals and health systems in discussing these issues.
Member

340B Advocacy Alliance Bulletin - February 9, 2026

New administrative process begins on 340B rebate models; hospitals should begin working on comment letters now.
Member

340B Advocacy Alliance Bulletin - February 5, 2026

Blog: 340B is a Solution, not a Threat to Health Care Affordability
Member

Update: Congress Passes Health Care Funding, Extends Key Health Care Provisions

Congress has passed the Consolidated Appropriations Act of 2026 (H.R.7148), which consists of a short-term continuing resolution for the Department of Homeland Security (DHS) appropriations bill and a package of five full-year appropriations bills, containing conferenced legislation for the Departments of Defense, Labor, Health and Human Services, Education,
Public

Fact Sheet: The 340B Drug Pricing Program

Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and communities they serve.
Member

340B Advocacy Alliance Bulletin - January 26, 2026

AHA urges HRSA to stop Eli Lilly’s new claims-data submission policy on 340B hospitals from going into effect; hospitals urged to submit their own letters to HRSA and use AHA letter as a guide.